| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 44,697 | $109,955 | $2.46 | 27 Aug 2024 | Direct |
| OptiNose, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $9.10 | 21 May 2025 | Direct |
| Verrica Pharmaceuticals Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 80,000 | 15 Mar 2024 | Direct | ||
| OptiNose, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPTN | OptiNose, Inc. | 21 May 2025 | 3 | $0 | 4 | Chief Financial Officer | 21 May 2025, 09:26 |
| OPTN | OptiNose, Inc. | 21 Feb 2025 | 2 | $0 | 4 | Chief Financial Officer | 26 Feb 2025, 20:00 |
| OPTN | OptiNose, Inc. | 07 Oct 2024 | 2 | $0 | 4 | Chief Financial Officer | 07 Oct 2024, 18:40 |
| OPTN | OptiNose, Inc. | 07 Oct 2024 | 0 | $0 | 3 | Chief Financial Officer | 07 Oct 2024, 18:39 |
| VRCA | Verrica Pharmaceuticals Inc. | 26 Aug 2024 | 2 | -$77,473 | 4 | CHIEF FINANCIAL OFFICER | 28 Aug 2024, 16:15 |
| VRCA | Verrica Pharmaceuticals Inc. | 15 Mar 2024 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 19 Mar 2024, 16:31 |
| VRCA | Verrica Pharmaceuticals Inc. | 14 Nov 2023 | 2 | -$82,671 | 4 | Chief Financial Officer | 16 Nov 2023, 16:34 |
| VRCA | Verrica Pharmaceuticals Inc. | 24 Aug 2023 | 1 | $0 | 4/A | CHIEF FINANCIAL OFFICER | 06 Feb 2025, 16:15 |
| VRCA | Verrica Pharmaceuticals Inc. | 01 Mar 2023 | 1 | $0 | 4 | Chief Financial Officer | 03 Mar 2023, 15:27 |
| VRCA | Verrica Pharmaceuticals Inc. | 24 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 25 Feb 2022, 15:33 |
| VRCA | Verrica Pharmaceuticals Inc. | 16 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 20 Jul 2021, 18:04 |
| VRCA | Verrica Pharmaceuticals Inc. | 16 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 20 Jul 2021, 17:59 |